Method for predicting the response of a patient to treatment with an anti-TNF alpha antibody

Details for Australian Patent Application No. 2008252657 (hide)

Owner UCL Business PLC

Inventors Ehrenstein, Michael; Mauri, Claudia

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008252657

PCT Pub. Number WO2008/142405

Priority 0709803.1 22.05.07 GB

Filing date 20 May 2008

Wipo publication date 27 November 2008

International Classifications

G01N 33/50 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Chemical analysis of biological material, e.g. blood, urine

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

17 December 2009 PCT application entered the National Phase

  PCT publication WO2008/142405 Priority application(s): WO2008/142405

31 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008252658-Methods for maximizing second fracture length

2008252656-Electrosurgical generator